Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
NEJM Evidence|May 30, 2024
Prostate Cancer Foundation Screening Guidelines for Black Men in the United StatesIsla P Garraway, Sigrid V Carlsson, Yaw A Nyame, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
European Urology Oncology|June 1, 2025
The Burden of Genitourinary Malignancies in Southeast Asia from 1990 to 2021Rod Carlo A Columbres, Aryan Selokar, Sybil Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across CarcinomasShuang G Zhao, William S Chen, Rajdeep Das, et al.
Cancer Cell|October 10, 2018
Integrated Analysis of Genetic Ancestry and Genomic Alterations across CancersJiao Yuan, Zhongyi Hu, Brandon A Mahal, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Pageof 21